To test and explore the viability of targeting mTOR to regulate CD4+ T-cell autophagy in sepsis as a way to minimize CTLA4 accumulation and hence alleviate CD4+ T-cell dysfunction, we employed rapamycin, a particular mTOR inhibitor, to corroborate the genetic approach's results. The gene discussed is CD4; the disease is Sepsis.